SPARK Trial: New Treatment for Triple-Negative Breast Cancer
In the evolving landscape of cancer treatment, a pivotal study uncovers promising results involving the combination of Sitravatinib and Tislelizumab ...
In the evolving landscape of cancer treatment, a pivotal study uncovers promising results involving the combination of Sitravatinib and Tislelizumab ...
In a groundbreaking advance that could shift the paradigm of triple-negative breast cancer therapy, researchers have unveiled promising results from ...
A groundbreaking discovery at Oregon Health & Science University (OHSU) has unveiled a novel therapeutic candidate with the potential to ...
A groundbreaking antibody therapy developed by scientists at King’s College London shows promising potential in restricting the growth of treatment-resistant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine